US CDC Leadership Transition Set; Timing Sidesteps Potential Rx Pricing Debate

President Biden has selected a new director for the US Centers for Disease Control and Prevention, and the pick – former CMS official Mandy Cohen – is likely to be the last who is not subject to confirmation in the Senate. That is an important nuance in the current political climate for drug pricing policies.

US Centers for Disease Control and Prevention building
Legislators will keep an eye on how the new director navigates CDC changes. • Source: Shutterstock

More from Legislation

More from Pink Sheet